[HTML][HTML] Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
Background Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
CT Bramante, NE Ingraham, TA Murray… - The Lancet Healthy …, 2021 - experts.umn.edu
Background: Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
[HTML][HTML] Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
CT Bramante, NE Ingraham, TA Murray… - The Lancet Healthy …, 2021 - covid19.sld.cu
Background Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
CT Bramante, NE Ingraham… - The lancet. Healthy …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
CT Bramante, NE Ingraham… - The Lancet Healthy …, 2021 - scholarship.miami.edu
Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors for severe
COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory effects …
COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory effects …
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
CT Bramante, NE Ingraham, TA Murray… - The lancet. Healthy …, 2020 - europepmc.org
Background Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
[HTML][HTML] Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
CT Bramante, NE Ingraham, TA Murray… - The Lancet Healthy …, 2021 - thelancet.com
Background Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
[HTML][HTML] Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
CT Bramante, NE Ingraham, TA Murray… - The Lancet. Healthy …, 2021 - ncbi.nlm.nih.gov
Background Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
[HTML][HTML] Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
CT Bramante, NE Ingraham, TA Murray… - The Lancet Healthy …, 2021 - Elsevier
Background Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
[PDF][PDF] Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
CT Bramante, NE Ingraham, TA Murray, S Marmor… - 2020 - covid19.sld.cu
Background Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …
for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory …